# Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting

> **NCT02076529** · NA · COMPLETED · sponsor: **Chonnam National University Hospital** · enrollment: 51 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Ramosetron 0.3mg
- **DRUG:** Ramosetron 0.45mg
- **DRUG:** Ramosetron 0.6mg

## Key facts

- **NCT ID:** NCT02076529
- **Lead sponsor:** Chonnam National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2014-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02076529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02076529, "Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02076529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*